Author:
Sawaki Akira,Ohashi Yasuo,Omuro Yasushi,Satoh Taroh,Hamamoto Yasuo,Boku Narikazu,Miyata Yoshinori,Takiuchi Hiroya,Yamaguchi Kensei,Sasaki Yasutsuna,Nishina Tomohiro,Satoh Atsushi,Baba Eishi,Tamura Takao,Abe Takashi,Hatake Kiyohiko,Ohtsu Atsushi
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Gastroenterology,Oncology,General Medicine
Reference19 articles.
1. Foundation for Promotion of Cancer Research. Cancer Statistics in Japan 2010. Available from http://ganjoho.ncc.go.jp/public/statistics/backnumber/2010_en.html . Accessed 30 June 2011.
2. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215–21.
3. Hudis CA. Trastuzumab—mechanism of action and use in clinical practice. N Engl J Med. 2007;357:39–51.
4. Bang Y-J, Chung HC, Xu JM, Lordick F, Sawaki A, Lipatov O, et al. Pathological features of advanced gastric cancer: relationship to human epidermal growth factor receptor 2 positivity in the global screening programme of the ToGA trial. J Clin Oncol. 2009;27:abstract 4556.
5. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707–12.
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献